Reuters Health: COVID vaccine proved safe, well tolerated in patients with rheumatic diseases
UC expert recommends further study differentiates between treatment, disease types
A new European study recently published in the Annals of Rheumatic Diseases shows that currently available COVID-19 vaccines rarely cause flares in patients with rheumatic and musculoskeletal disease. Flares were reported in less than 5% of all cases within the study.
While encouraging, Wenhai Shao, PhD, associate professor in the Division of Immunology, Allergy and Rheumatology in the University of Cincinnati's Department of Internal Medicine, told Reuters Health that further studies should differentiate whether patients are taking immunosuppressants or other types of drugs, compare to healthy individuals and note the severity of the rheumatic or musculoskeletal diseases when the vaccination was given for more specific results.
"A bioinformatics approach could be used to analyze the data in these different ways," Shao said.
Read the Reuters Health article.
Featured photo at top of vaccination courtesy of Shutterstock.com
Related Stories
What is the 'cicada' COVID variant?
April 6, 2026
A formerly rare strain of COVID, BA.3.2, now is showing up in Ohio and 24 other states. Experts say so far it hasn't caused illness any more severe than other strains, but it might be somewhat more resistant to vaccines, as 91.7 WVXU News recently reported. Scientists have nicknamed the variant "cicada" due to its former low profile and current resurgence.
UC opens zebrafish research facility to study infertility
April 6, 2026
The University of Cincinnati is launching a state-of-the-art zebrafish research facility that scientists say could help explain how environmental toxins affect fertility, as WKRC-TV/Local 12 and WLWT-TV/Ch. 5 recently reported.
UC launches new Center for Public Health
April 6, 2026
The University of Cincinnati College of Medicine recently announced Suzanne Judd, PhD, as the inaugural director of its new Center for Public Health. The hire follows a national search launched in August 2025, as the Cincinnati Business Courier reported.